[Glutamate antagonist].
Shindo
M
M
Shinshu University Health Center, Matsumoto, Japan.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000401:mortality; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019782:Riluzole / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate
D018691:Excitatory Amino Acid Antagonists; D019782:Riluzole